These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2115035)

  • 1. Prevalence of resistance of aerobic gram-negative bacilli to broad-spectrum antibacterial agents: results of a multicentre study.
    Kresken M; Jansen A; Wiedemann B
    J Antimicrob Chemother; 1990 Jun; 25(6):1022-4. PubMed ID: 2115035
    [No Abstract]   [Full Text] [Related]  

  • 2. Survey of antibiotic susceptibility among gram-negative bacilli at a cancer center.
    Rolston KV; Elting L; Waguespack S; Ho DH; LeBlanc B; Bodey GP
    Chemotherapy; 1996; 42(5):348-53. PubMed ID: 8874974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of aminoglycoside-induced adaptive resistance on the antibacterial activity of other antibiotics against Pseudomonas aeruginosa in vitro.
    Barclay ML; Begg EJ; Chambers ST; Peddie BA
    J Antimicrob Chemother; 1996 Nov; 38(5):853-8. PubMed ID: 8961055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The in-vitro activity of piperacillin/tazobactam, ciprofloxacin, ceftazidime and imipenem against multiple resistant gram-negative bacteria.
    Mehtar S; Drabu YJ; Blakemore PH
    J Antimicrob Chemother; 1990 Jun; 25(6):915-9. PubMed ID: 2164513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Changes of antimicrobial resistance among nonfermenting gram-negative bacilli isolated from intensive care units from 1994 to 2001 in China].
    Wang H; Chen MJ;
    Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):385-90. PubMed ID: 12820914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative in vitro antimicrobial activity of carumonam, a new monocyclic beta-lactam.
    Smith BR; LeFrock JL; McCloskey RV; Donato JB; Weber SJ; Joseph WS
    Antimicrob Agents Chemother; 1986 Feb; 29(2):346-9. PubMed ID: 3087280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative activities of three new antibacterial agents with aztreonam against gram-negative bacilli.
    Kafetzis DA; Legakis NJ
    Chemioterapia; 1987 Jun; 6(2 Suppl):110-2. PubMed ID: 3151330
    [No Abstract]   [Full Text] [Related]  

  • 8. Antimicrobial activity of isepamicin (SCH21420, 1-N-HAPA gentamicin B) combinations with cefotaxime, ceftazidime, ceftriaxone, ciprofloxacin, imipenem, mezlocillin and piperacillin tested against gentamicin-resistant and susceptible gram-negative bacilli and enterococci.
    Jones RN; Johnson DM; Barrett MS; Erwin ME
    J Chemother; 1991 Oct; 3(5):289-94. PubMed ID: 1809808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survey of antibiotic susceptibility among gram-negative bacilli at a cancer hospital.
    Bodey GP; Ho DH; Elting L
    Am J Med; 1988 Jul; 85(1A):49-51. PubMed ID: 3041819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of ceftazidime and newer antibiotics against Gram-negative bacilli.
    Schassan HH; Fedder J
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():79-82. PubMed ID: 19802973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular epidemiology of antibiotic-resistant gram-negative bacilli in a neonatal intensive care unit during a nonoutbreak period.
    Toltzis P; Dul MJ; Hoyen C; Salvator A; Walsh M; Zetts L; Toltzis H
    Pediatrics; 2001 Nov; 108(5):1143-8. PubMed ID: 11694694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial susceptibility profiles of Gram-negative bacilli isolated from patients with hepatobiliary infections in Taiwan: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2006-2010.
    Toh HS; Chuang YC; Huang CC; Lee YL; Liu YM; Ho CM; Lu PL; Liu CE; Chen YH; Wang JH; Ko WC; Yu KW; Liu YC; Chen YS; Tang HJ; Hsueh PR
    Int J Antimicrob Agents; 2012 Jun; 40 Suppl():S18-23. PubMed ID: 22749054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of meropenem against ciprofloxacin-resistant enterobacteriaceae and Pseudomonas aeruginosa.
    Garcia-Rodriguez JA; Blazquez AM; Fresnadillo MJ; Garcia Sanchez E; Garcia Sanchez JE; Trujillano Martin I
    J Chemother; 1996 Oct; 8(5):358-64. PubMed ID: 8957715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative in vitro activity of 2 monobactams (RO 172301 (AMA 1080)and aztreonam), ceftazidime and cefotaxime on Gram-negative bacilli].
    Thabaut A; Meyran M; Huerre M
    Pathol Biol (Paris); 1985 May; 33(5):404-7. PubMed ID: 3929217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pseudomonas aeruginosa bacteremia: associations with a source of infection and antibiotic resistance].
    Dambrauskiene A; Adukauskiene D; Jeroch J; Vitkauskiene A
    Medicina (Kaunas); 2009; 45(1):1-7. PubMed ID: 19223699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiply antibiotic-resistant gram-negative bacilli in a long-term-care facility: a case-control study of patient risk factors and prior antibiotic use.
    Muder RR; Brennen C; Drenning SD; Stout JE; Wagener MM
    Infect Control Hosp Epidemiol; 1997 Dec; 18(12):809-13. PubMed ID: 9442404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study quantifies impact of resistant Pseudomonas on outcomes.
    Kepple SR
    Am J Health Syst Pharm; 1999 Jul; 56(14):1392. PubMed ID: 10428444
    [No Abstract]   [Full Text] [Related]  

  • 18. Susceptibility to beta-lactam antibiotics and gentamicin of gram-negative bacilli isolated from hospitalized patients: a Swedish multicenter study.
    Dornbusch K; Bengtsson S; Brorson JE; Fritz H; Henning C; Kronvall G; Larsson P; Malmborg AS; Thore M; Tärnvik A
    Scand J Infect Dis; 1988; 20(6):641-7. PubMed ID: 3065931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial resistance surveillance of bacteria in 1999 in Korea with a special reference to resistance of enterococci to vancomycin and gram-negative bacilli to third generation cephalosporin, imipenem, and fluoroquinolone.
    Lee K; Lee HS; Jang SJ; Park AJ; Lee MH; Song WK; Chong Y;
    J Korean Med Sci; 2001 Jun; 16(3):262-70. PubMed ID: 11447969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of ceftazidime-avibactam against 338 molecularly characterized gentamicin-nonsusceptible Gram-negative clinical isolates obtained from patients in Canadian hospitals.
    Denisuik AJ; Karlowsky JA; Denisuik T; Nichols WW; Keating TA; Adam HJ; Baxter M; Walkty A; Zhanel GG
    Antimicrob Agents Chemother; 2015; 59(6):3623-6. PubMed ID: 25824208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.